🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 18 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/01/2010 36,56 37,57 36,36 37,15 +3,67% 3,31% 26.593.419
12/01/2010 36,09 36,25 35,61 35,83 -0,79% 1,77% 11.445.942
11/01/2010 36,15 36,18 35,78 36,12 +0,40% 1,11% 10.041.726
08/01/2010 36,14 36,15 35,72 35,97 -0,05% 1,21% 11.283.921
07/01/2010 35,75 36,16 35,69 35,99 +0,16% 1,33% 12.488.597
06/01/2010 35,51 36,00 35,21 35,94 +1,35% 2,23% 15.971.415
05/01/2010 35,59 35,73 35,24 35,46 +0,41% 1,39% 15.452.550
04/01/2010 35,13 35,54 34,88 35,31 +1,29% 1,90% 14.563.532
31/12/2009 35,11 35,37 34,83 34,87 -1,40% 1,55% 7.403.072
30/12/2009 35,19 35,49 35,12 35,36 -0,11% 1,03% 9.838.205
29/12/2009 35,43 35,78 35,37 35,40 -0,51% 1,16% 7.869.013
28/12/2009 35,30 35,67 35,11 35,58 +0,81% 1,59% 10.443.634
24/12/2009 35,44 35,44 35,08 35,30 -0,70% 1,02% 6.586.890
23/12/2009 36,13 36,13 35,44 35,54 -1,32% 1,90% 13.358.542
22/12/2009 36,06 36,24 35,83 36,02 +0,16% 1,14% 14.771.350
21/12/2009 35,76 36,66 35,75 35,96 +0,78% 2,53% 15.497.090
18/12/2009 35,65 36,06 35,50 35,69 +0,32% 1,58% 26.643.618
17/12/2009 36,02 36,12 35,55 35,57 -1,25% 1,56% 19.433.483
16/12/2009 36,28 36,36 35,80 36,02 -0,66% 1,53% 17.476.238
15/12/2009 35,94 36,26 35,56 36,26 +0,61% 1,94% 13.495.096
14/12/2009 35,56 36,07 35,56 36,04 +1,89% 1,42% 12.981.262
11/12/2009 35,67 35,67 35,18 35,37 -1,25% 1,36% 14.402.769
10/12/2009 35,70 36,18 35,68 35,82 +1,05% 1,42% 15.336.642
09/12/2009 34,64 35,52 34,45 35,45 +2,20% 3,11% 18.611.537
08/12/2009 34,97 35,30 34,60 34,69 -0,95% 1,99% 16.286.234
07/12/2009 34,85 35,34 34,81 35,02 +0,00% 1,53% 10.448.036
04/12/2009 35,51 35,78 34,96 35,02 -0,19% 2,31% 17.412.415
03/12/2009 35,03 35,34 34,88 35,09 -0,08% 1,33% 13.639.406
02/12/2009 34,83 35,31 34,78 35,11 -0,22% 1,51% 12.601.990
01/12/2009 34,63 35,52 34,63 35,19 +1,85% 2,59% 17.421.533